The story of Sildenafil presents a interesting case for observers in the pharmaceutical sector. While initially a blockbuster success, generating billions, the intellectual property lapse and the subsequent entry of https://porn938422.ambien-blog.com/48650840/the-little-copyright-and-pharma-a-risky-play